What Is NAD+? A Plain Explanation of the Compound

Summary: NAD+ is an endogenous coenzyme, not a synthetic peptide. Most of the human research attached to its name studied oral precursors rather than injected NAD+.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

What is NAD+? It is a coenzyme that every cell in your body already makes, uses and remakes continuously. Nicotinamide adenine dinucleotide, to give the full name, sits at the centre of how cells handle energy, shuttling between two forms as chemical reactions hand electrons back and forth.

You are not deficient in it in the way you might be deficient in a vitamin you never eat. Your cells build it, spend it, and rebuild it, all day, without any instruction from you. That single fact separates NAD+ from almost everything else discussed on this site, and it is the fact most likely to be quietly dropped when the molecule is sold. So the question what is NAD+ has a short answer and a longer one, and the longer one is where the selling happens.

What is NAD+ actually doing inside a cell

Think of it as a carrier rather than a fuel. Reactions that break down food to release energy need something to accept electrons, and reactions that build molecules up need something to donate them. NAD+ and its reduced partner do that job, cycling between the two states so the same molecules can be used over and over.

Certain enzymes also consume NAD+ rather than simply borrowing it, which means the cell has to replace what those enzymes use. That replacement happens through salvage routes that recycle breakdown products back into fresh coenzyme, and through building it from dietary components. The system runs continuously and it is regulated.

This is textbook cell biology, not a claim about a product. It is worth stating because the marketing rests on it: the pitch is that this essential molecule declines, and that topping it up restores something. The biology being real does not make the second half of that follow.

Four different things sold under the same banner

The rows matter more than they look. When a page says NAD+ has been studied extensively in humans, it is usually describing rows two and three while pointing at row one. Answering what is NAD+ therefore means asking which row a given page is talking about.

Not a peptide, and not like the rest of this catalogue

Every other compound this site covers is a synthetic peptide or a peptide fragment, made in a laboratory, foreign to the body until injected. NAD+ is a different kind of object. It is a nucleotide coenzyme, it is endogenous, and its chemistry has been understood for a very long time.

That difference cuts two ways, and both halves are usually reported selectively.

In its favour, this is not a speculative molecule of uncertain identity. Nobody is arguing about whether NAD+ exists or what it does in metabolism. Against it, being endogenous tells you nothing about what happens when a manufactured version is pushed into a vein at a quantity your cells did not ask for. Insulin is endogenous. Thyroid hormone is endogenous. Both are given as medicines, both are dangerous outside their proper use, and neither is safe because your body makes it. Origin is not a safety argument.

There is a further consequence of the difference that is easy to miss. Because NAD+ is endogenous, it can be measured in people who have taken nothing at all, and studies that measure it in ordinary populations are genuinely human studies. Those get cited as human evidence for the product. Measuring how much of a coenzyme someone already has is a different exercise from giving them a manufactured version and watching what follows. The first describes a population. The second is an intervention, and only interventions can support a benefit claim.

Why the precursors exist at all

There is a practical reason the human trials study NR and NMN rather than NAD+ itself, and understanding it explains most of the confusion.

Precursors are designed to be taken by mouth and converted inside the body into the coenzyme. That makes them convenient to study: a capsule, a placebo capsule that looks identical, a trial that can run for weeks in ordinary participants. Intravenous NAD+ requires a clinic, a line, staffed time and a much larger commitment from everyone involved, which is one reason far fewer controlled human studies of it exist.

So the literature grew where the research was easiest to do. That is a completely normal way for a field to develop. The problem arrives when the resulting evidence is presented as support for the harder to study version that people are actually buying.

The premise the whole category rests on

Almost every page selling this molecule leans on one idea: that NAD+ levels fall as people age, and that restoring them reverses something. It is worth taking that idea apart, because a reader who accepts it whole has accepted three separate claims as though they were one.

The first claim is that levels change with age. That is a statement about measurement, and a careful version of it has to say which tissue was measured, in which organism, and by what method. Blood is not muscle, and muscle is not brain. A finding in one does not automatically describe the others.

The second claim is that a given product raises those levels. This one has to name the intervention. An oral precursor and an intravenous infusion are different exposures with different handling by the body, and evidence that one raises a measured level says nothing about the other until someone tests the other.

The third claim is the one buyers actually care about, and it is the least supported: that raising a level produces an outcome a person would notice. Energy, clarity, sleep, ageing itself. This is the step where a great deal of biochemistry has to turn into a human result, and it is exactly the step that a page about cellular energy metabolism can skip without the reader noticing, because the first two claims sound like they imply it.

They do not. Biology is full of measurable quantities that can be moved without anything downstream changing. Moving a marker is a hypothesis about benefit, not a demonstration of one, and the demonstration requires a trial with a comparison group in humans, measuring an outcome rather than a marker.

None of this means the premise is wrong. It means it is three claims, each needing its own evidence, and each needing the organism and the intervention named. When you see the whole chain compressed into one sentence, the compression is where the argument is being made.

Where the injected version sits

Injected or infused NAD+ has no marketing authorisation. No medicines regulator has approved it as a treatment for anything, which means there is no labelled dose, no approved indication, no listed contraindications and no adverse effect frequencies compiled by anyone with an obligation to compile them.

It is supplied instead through wellness clinics offering infusions and through vials sold as research chemicals. Those are distribution channels, not quality assurances. Neither carries the identity testing, concentration assay and sterility guarantee that pharmaceutical manufacture involves, and neither creates a person who is accountable if a batch is wrong.

First questions people ask about the molecule

Is NAD+ a peptide?

No. It is a nucleotide coenzyme built from two nucleotides joined together. Peptides are chains of amino acids. The two are different classes of molecule, and NAD+ is only grouped with peptides because it is sold through the same channels.

If my body already makes it, is more of it harmless?

That does not follow. The body regulates its own production and recycling. Introducing a manufactured version from outside, at a quantity nobody has established, bypasses that regulation entirely. Endogenous origin describes where a molecule comes from, not what happens when you add more.

Does taking a precursor raise NAD+ in the body?

Precursor trials in humans measure what they measure, and any specific claim needs to name which precursor, which tissue and which measurement. The more important gap for a reader is a different one: raising a measurable level is not the same as producing an outcome a person would notice, and those two claims get conflated constantly.

Why is there so much research if the injected product is unproven?

Because the research is mostly about something else. NAD biology is a major field in basic science, and most of the interventional work in humans used oral precursors. Volume of literature about a molecule is not the same as evidence for a particular product containing it.

What is the single most useful thing to keep from this?

Ask which intervention was studied. Precursor by mouth and NAD+ into a vein are different exposures, and a claim that does not say which one it came from has not told you enough to judge it.